|
|
||||||||
Ann Thorac Surg 1996;62:1696-1697
© 1996 The Society of Thoracic Surgeons
| The first 20% of the full text of this article appears below. |
See also page 1691.
DR GEORGE M. PALATIANOS (Athens, Greece): We have been using leukocyte-filtered blood cardioplegia for the last 2
years. We have seen that the patients in whom we use this type of cardioplegia have less arrhythmogenic activity postoperatively, less reperfusion ventricular fibrillation, and a smaller need for antiarrhythmics. Also we have noticed less use of inotropic agents postoperatively. These are our clinical observations. I would like to ask you to comment on this protective effect of the leukocyte-depleted cardioplegic solution against the postoperative arrhythmogenic activity.
My
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |